SpaceX bonds sell off days after AI and rocket group’s $25bn debt deal - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

SpaceX bonds sell off days after AI and rocket group’s $25bn debt deal

Yields move towards levels commonly associated with junk-rated companies
00:00

{"text":[[{"start":9.3,"text":"SpaceX’s bonds dropped in price on Friday, just days after it raised $25bn in a blockbuster debt deal, as investors cast doubts over the long-term prospects of Elon Musk’s rocket and AI company. "}],[{"start":23.700000000000003,"text":"The yield on the group’s 10-year debt rose to almost 6 per cent, pushing the gap with Treasuries, known as the “spread”, to above 1.6 percentage points, up 0.2 percentage points from when the debt was issued this week."}],[{"start":36.5,"text":"SpaceX was among the worst performers in the high-grade bond market on Friday, MarketAxess data shows."}],[{"start":43.25,"text":"The sell-off means the company’s bonds are trading at levels closer to those of junk-rated borrowers, despite the group’s investment-grade status from major rating agencies. SpaceX paid a higher borrowing cost than similarly rated companies during its bond sale on Tuesday."}],[{"start":60.5,"text":"“In investment-grade credit, what we focus on is whether a company can service its debt,” said Michael Campion, a portfolio manager at PGIM, referring to lossmaking borrowers in general. “We’re used to lending based on actual cash flows rather than expectations.”"}],[{"start":76.6,"text":"SpaceX posted a net loss of $4.9bn on revenues of $18.7bn in 2025. "}],[{"start":85.14999999999999,"text":"The company raised $86bn in an initial public offering earlier this month at a $1.78tn valuation that rests on projections that its AI revenues will surge in coming years."}],[{"start":97.69999999999999,"text":"The group’s equity has swung wildly since the IPO, sending its market value to almost $3tn at its peak before sinking to $2tn. "}],[{"start":106.89999999999999,"text":"SpaceX’s borrowing shortly after its record-breaking IPO is a clear sign that markets are entering “bubble territory”, Ludovic Subran, chief investment officer at Allianz, told delegates at this week’s FT Global Insurance Summit. "}],[{"start":121.1,"text":"“Bond investors are not the same as equity investors. Equity investors, you can take them to Mars. Bond investors are, like, ‘where is my coupon?’,” Subran said. "}],[{"start":131.4,"text":"In a sign of fragile investor confidence over SpaceX’s prospects, the company’s long-term debt is under even more severe selling pressure. Its bonds maturing in 2046 and 2056 were trading at spreads of 1.93 and 2.01 percentage points, respectively, compared to 1.65 and 1.75 percentage points at issuance, MarketAxess data shows."}],[{"start":155.85,"text":"Credit spreads on a basket of US corporate bonds with similar triple B ratings — the lowest investment-grade score — were 0.95 percentage points, while those for speculative-grade borrowers with a double B rating were 1.67 percentage points, according to Ice Data Services. "}],[{"start":174.79999999999998,"text":"SpaceX’s heavy reliance on Musk’s leadership, combined with the absence of a succession plan, have made its long-term debt less attractive, said James Dow, professor at London Business School. "}],[{"start":187.29999999999998,"text":"“Right now, the company’s value depends on [Musk] . . . but he’ll be very old in 30 years,” Dow said. “The corporate governance is exceptionally weak.”"}],[{"start":205.45,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1782539520_7126.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

谷歌为Anthropic打造的2000亿美元华尔街融资机器

私募信贷、芯片租赁和数据中心担保,支撑起AI支出的全新庞大模式。

“日元干预”等于“美国自保”

美国联手日本支撑日元,不只是出于盟友情谊,更是为了避免日本加息或美国国债遭抛售、导致美债收益率进一步走高。

“诅咒之岛”:科技游民与诈骗犯藏身的千亿美元奢华开发项目

警方的突击搜查再次打击了马来西亚陷入困境的中资“森林城市”项目的声誉。

问题不在因凡蒂诺

马杜罗:应该将国际足联的监管职能与商业活动分开,其治理应真正做到包容并具有代表性,监督必须真正独立。

俄罗斯扩大“影子”液化天然气船队,应对欧盟禁令

随着明年制裁进一步收紧,越来越多的“影子”船舶将帮助俄罗斯继续出口液化天然气。

阿斯利康与百时美施贵宝:大药企有时也不够大

当资产负债表规模扩大、能够押注潜在重磅药物时,规模才会带来优势。
设置字号×
最小
较小
默认
较大
最大
分享×